ABSTRACT: Epigallocatechin gallate (EGCG) is a polyphenol that is abundant in green tea. It has been reported that consumption of EGCG can contribute to weight loss, however, the underlying mechanism is not fully understood. To determine how EGCG reduces body fat, an organism model Caenorhabditis elegans was used, which is a useful animal model system in exploring crucial biological mechanisms that are readily applicable to humans. In this study, different strains were raised for two days on Escherichia coli OP 50 diet with or without 100 M and 200 M EGCG treatment. The current results showed that 100 M and 200 M EGCG significantly reduced the triglyceride content of wild type worms by 10% and 20% (P-value<0.01 and <0.001, respectively) compared to the control, respectively, without affecting its food intake and physiological behaviors. Additionally, EGCG could effectively reduce fat accumulation in C. elegans dependent on atgl-1 (encoding a homolog of adipose triglyceride lipase), which suggests that EGCG controls the body fat by inhibiting adipogenesis.
INTRODUCTION
Green tea is a popular beverage with a high content of flavonoids (a natural polyphenol) and is known to have many desirable health benefits, such as anti-carcinogenic, anti-inflammatory, and anti-oxidative effects (1) . Epigallocatechin-3-gallate (EGCG) is the most abundant catechin in green tea, which is believed to be responsible for those bioactivities in green tea (2) . EGCG has been reported to have fat reduction effects by inhibiting energy intake in diet-induced obese mice (3, 4) , inhibiting lipogenesis in vitro (5, 6) , inhibiting -amylase activity in vitro (7) , inhibiting lipid digestion and absorption in high fatfed mice (8) , stimulating energy expenditure in vivo (9) , promoting fat oxidation both in vivo (10) and in vitro (11) , and promoting lipolysis (12, 13) .
Caenorhabditis elegans has been used extensively in biological and medical studies due to their short life span of ∼20 days, a reproductive cycle of 3 days, and a large brood size of about 300 eggs by self-fertilization (14) . Moreover, it conserves 65% of genes related to human diseases (15) , including those related to lipid metabolism, which makes it a great in vivo model for cellular and genetic studies. In C. elegans, EGCG has been previously shown to display antioxidant activities (16) , reduce stress related responses (17) , and extend longevity (18) . However, there is no report of EGCG on the fat reduction effect in C. elegans. Therefore, this study was to examine whether EGCG could play a role in reducing fat content in C. elegans.
MATERIALS AND METHODS

Materials
The C. elegans strains and Escherichia coli OP50 used in this study were obtained from the Caenorhabditis Genetics Center (CGC, University of Minnesota, Minneapolis, MN, USA), including N2, bristal (wildtype); CE541, sbp-1 (ep79) III; RB754, aak-2 (ok524) X; RB1716, nhr-49 (ok2165) I; BX107, fat-5 (tm420) V; BX106, fat-6 (tm331) IV; BX153, fat-7 (wa36) V; RB1600, tub-1 (ok1972) II; GR1307, daf-16 (mgdf50); OP50 and OP50-green fluorescent protein (GFP) E. coli. EGCG (purity >99%) and the Infinity TM Triglycerides Reagent were purchased from Fisher Scientific (Pittsburgh, PA, USA). The Coomassie Plus Protein Assay Reagent was obtained from Thermo Fisher Scientific (Middletown, VA, USA). 5-Fluoro-2'-deoxyuridine (FUdR) was purchased from Sigma-Aldrich Co. (St. Louis, MO, USA). Household bleach (The Clorox Values with ** or *** show significant difference when compared with the control (P -value <0.01 or <0.001, respectively).
Company, Oakland, CA, USA) was used for bleaching the worms when synchronizing L1 worms.
Preparation of EGCG solution and worm culture
The EGCG was dissolved in sterilized water and filtered through a 0.22 m-diameter membrane prior to use. Previously, it was reported that 200∼400 M EGCG was the optimal concentration for increasing lifespan in C. elegans (19) , thus, we chose 100 M and 200 M EGCG as treatment groups to study the fat reducing effects in C. elegans.
M9 buffer, S-complete, and nematode growth media (NGM) agar were used in the C. elegans cultures (20) . After synchronizing, all L1 worms were raised at 25 o C in S-complete media supplemented with E. coli OP50 and treated with or without EGCG for 2 days.
Triglyceride quantification
After 2 days of EGCG treatment, C. elegans was collected and washed twice with water to remove E. coli and EGCG. C. elegans samples were dissolved in 0.05% Tween 20 solution. After sonication, the samples were used for the triglyceride (TG) and protein measurements. The TG assay was conducted with the Infinity TM Triglycerides Reagent and protein content was measured with the Coomassie Plus Protein Assay Reagent (21) . TG content was then normalized with protein concentrations.
Measurement of growth rate, body size, movement, and food intake
After the 2-day treatment, nematodes were transferred to new agar plates to measure the growth rate. For each treatment group, ∼50 worms were randomly selected and paralyzed using 10 mM NaN3 (22, 23) . The numbers of worms at different stages were counted under an optical microscope (Olympus Corporation, Tokyo, Japan).
After the 2-day treatment, nematodes were transferred to new plates with fresh E. coli OP50 for the measurement of body size and movement (22) . A 30-s video was recorded and used for the length, width, and moving speed of worms using the Wormlab tracking system (WormLab software version 3.1.0, MicroBrightField Inc., Williston, VT, USA).
To monitor food intake of the nematodes, age-synchronized N2 nematodes were cultivated on E. coli OP50-GFP bacterial lawns on NGM plates with or without EGCG (24) . After treatment for 2 days, nematodes were washed twice with water, placed, and fixed onto slides, which were prepared with fresh 5% agar pads, and then visualized under a fluorescent microscope. The integrated density was quantified using Image J software (U.S. National Institutes of Health, Bethesda, MD, USA) by determining the average pixel intensity. The pumping rate was also measured by counting the rate of pharyngeal muscle contractions from C. elegans under the optical microscope (25) .
mRNA expression analysis
Total RNA was extracted from C. elegans using the TRIzol Ⓡ reagent under RNase-free conditions (22, 23) . Total RNA was reverse transcribed to cDNA using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Forster City, CA, USA). Real-time polymerase chain reaction (PCR) was performed on a StepOne Plus real-time PCR system (Applied Biosystems). We used cebp-2 (Ce02421574_g1), hosl-1 (Ce02494529_m1), atgl-1 (Ce02406733_g1), mdt-15 (Ce02406575_g1), pod-2 (Ce 02427721_g1), and acs-2 (Ce02486193_g1) for TaqMan gene expression assays. Threshold values were analyzed using the comparative CT method. The RNA polymerase II large subunit ama-1 gene (Ce02462726_m1) was used as an internal standard.
Statistical analysis
Data are expressed as means±standard errors (SE). Statistical analysis for all data was performed by the Statistical Analysis System (SAS version 9.4, SAS Institute, Cary, NC, USA). Data in Fig. 2B , 3A, 4, and 5 were analyzed by one-way ANOVA. Data in Fig. 1, 2A , and 3B∼D were analyzed by two-way ANOVA (treatment and experiment). No interaction between treatment and experiment were found in all data. Tukey's multiple comparison test was used to determine treatment effects. Differences was defined at the P<0.05 level. 
RESULTS
EGCG treatment decreased TG content without altering food intake
Treatment with EGCG significantly decreased the TG content in a dose-dependent manner, 10% (100 M) and 20% (200 M) decreases compared to the control (Fig.  1) . Pumping rate is a mechanical movement, which represents food intake in C. elegans (25) . Treatment of EGCG for 2 days had no effect on the pumping rate of wild type nematodes ( Fig. 2A) . We conducted another experiment using E. coli OP50-GFP to measure food intake. The analysis of fluorescent intensity (Fig. 2B) indicated that there was no significant difference between the treatment and control groups, which was consistent with the pumping rate. The representative images of C. elegans fed with E. coli OP50-GFP were shown in Fig. 2C . These results suggested that EGCG did not affect food intake in C. elegans.
EGCG had no effects on growth and development
Treatments of EGCG, at both 100 M and 200 M, showed no significant effect on growth rate (Fig. 3A) , body length (Fig. 3B) , and locomotive activities (Fig. 3D) . While at 200 M, the body width of the worms decreased compared with control (Fig. 3C) , which might be due to reduced body fat observed in Fig. 1 . Taken collectively, these data indicated that EGCG has no effect on the growth, body length, or locomotive activities, but has significant effect on body width at higher concentration in C. elegans.
EGCG potentiated lipolysis
Next, various mutant strains are known to be linked to lipid metabolism were tested, including sbp-1 (encoding an ortholog of sterol response element binding protein), nhr-49 (encoding nuclear hormone receptor and a functional ortholog of peroxisome proliferator-activated receptors), aak-2 (encoding one of two homologs of the AMP-activated protein kinases), tub-1 (encoding a homolog of TUBBY), fat-5, 6, and 7 (endoding delta 9 desaturase homologs), and daf-16 (encoding a homolog of the Forkhead box O transcription factor). Significant differences between the TG level of the control and EGCG treatment groups in these strains were observed, suggesting that effects of fat reduction by EGCG was independent to sbp-1, nhr-49, aak-2, tub-1, fat-5, fat-6, fat-7 , and daf-16 in C. elegans (Fig. 4) .
We further determined expressions of genes involved in lipid metabolism in wild-type C. elegans, including cebp-2 (encoding a homolog of the CCAAT/enhancer-binding protein), acs-2 (encoding a homolog of acyl-CoA synthetase), mdt-15 (a homolog of mediator complex subunit 15), pod-2 (encoding a homolog of acetyl-CoA carboxylase ), hosl-1 (encoding a homolog of hormone-sensitive lipase), and atgl-1 (encoding a homolog of the adipose triglyceride lipase). EGCG significantly decreased the expression of atgl-1 and acs-2 at both 100 M and 200 M compared to the control, while other genes showed no difference (Fig. 5) . These data indicated that the fat reduction effect of EGCG in C. elegans might be dependent on acs-2 and atgl-1.
DISCUSSION
In the present study, EGCG (100 M and 200 M) significantly reduced the fat accumulation in a dose-dependent manner in wild type worms without altering the food intake, growth rate, worm size, or locomotive activity. This is consistent with previous reports that EGCG treatments could reduce fat accumulation in high-fat fed rats (26) and that 100 M EGCG decreased the lipid accumulation of 3T3-L1 preadipocytes (6) . The current results fur-ther indicated that EGCG does not influence energy intake or physical activity (as a part of energy expenditure), suggesting its metabolic involvement on fat reduction.
It was previously reported that green tea catechins could decrease lipogenesis by inhibiting the activity and/ or expression of lipogenic enzymes, such as fatty acid synthase (FAS), sterol regulatory element-binding protein-1c, and stearoyl-CoA desaturase-1 in rodent animals (27) . In addition, EGCG was reported to reduce fat storage by activation of AMP-activated protein kinase in vitro (28) . However, the current results suggest that EGCG may not exert its fat reduction effects via fat-5, fat-6, fat-7, sbp-1, nhr-49, daf-16, or aak-2 in C. elegans. Since we have not determine the role of EGCG in FAS, it is possible that EGCG may act via FAS along with additional lipogenic enzymes, such as fatty acid elongase, and 3-ketoacyl-CoA reductase (LET-767) (29) . Alternatively, other catechins in green tea including epicatechin, epigallocatechin, and epicatechin-3-gallate (30), might contribute to decreasing fat content, not EGCG.
Tho and Wolfram (4) reported that dietary EGCG promoted fat oxidation in mice. Furthermore, one study in overweight/obese men showed that EGCG alone had the potential to promote fat oxidation and might thereby render an anti-obesity effect (10) . In C. elegans, acs-2 encodes an acyl-CoA synthetase, which catalyzes the conversion of a fatty acid to acyl-CoA for subsequent oxidation (31) . However, the current result suggests that EGCG reduced the expression of acs-2 in the wild type nematodes, which indicate that EGCG might inhibit fat oxidation although overall fat accumulation was still reduced in C. elegans. Similar discrepancies have been previously reported that low-fat phenotypes might lead to compensatory suppression of acs-2 transcription to prevent further energy expenditure (32) . Thus, we inferred that reduced expression of acs-2 by EGCG has no significance on its effect on overall body fat in this model. Alternatively, it is possible that the other mechanisms, such as post-translational regulation of acs-2 (33), is responsible for EGCG's fat reduction effect. This and other mechanisms may need to be further investigated.
There has been growing evidence that EGCG could enhance lipolytic activities in 3T3-L1 adipocytes (13) . However, Söhle et al. (12) reported that EGCG had no contribution on the stimulation effect of white tea extract on lipolysis in human subcutaneous adipocytes. The controversial statements, therefore, suggested that EGCG had inconsistent effects on lipolysis. ATGL is an adipose triglyceride lipase, which is responsible for lipolysis (34) . The current results showed that EGCG reduced the expression of atgl-1 in wild type nematodes, suggesting that EGCG inhibit lipolysis in C. elegans. However, in addition to be used as a marker for lipolysis, ATGL is also known to be used as a marker for adipogenesis as it remains highly expressed in mature adipocytes (35) . Thus, reduced atgl-1 expression by EGCG might suggest inhibition of adipogenesis, rather than reduced lipolysis. This is consistent with the in vitro studies conducted by Hwang et al. (6) and Moon et al. (28) . Overall the current results would not be enough to determine the potential mechanisms of fat reduction effects of EGCG, thus, additional research is needed to investigate the influence of acs-2 and atgl-1 at the post-translational level.
In summary, the current results conclude that effect of EGCG on fat reduction in C. elegans is dependent on atgl-1 and acs-2. EGCG might inhibit adipogenesis to decrease the fat content in C. elegans, as shown by the decreased atgl-1 gene expression level after EGCG treatment. Thus, consuming EGCG as a dietary supplement could potentially control the body fat content.
